Key facts
- Yazen’s last known valuation is $89.0M.
- It has raised $26.8M; the latest was Early Stage VC ($21.6M) in Oct 2024.
- Notable investors include Almaz Capital, Evli Growth Partners, Aggregate, Fast Track Malmo, Fåhraeus Startup and Growth Fund — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Yazen
- ·The full record, as it builds
Funding rounds
No funding rounds for Yazen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yazen
Developer of a digital healthcare application for middle-aged men intended to provide overweight and obesity management facilities. The company's application helps treat obesity and possible deficiency of testosterone hormone and its negative effect on health through connecting with a doctor, psychologist, dietitian, and personal trainer by suggesting some lifestyle changes based on data and in some cases through medication, enabling patients to improve their physical and mental well-being.
- Sector
- Healthcare
- HQ
- Lund, Sweden
- Founded
- 2021
- Employees
- 270
- Website
- yazen.com/
- Ownership
- Privately Held (backing)
Yazen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yazen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yazen in its N-PORT filings yet. We sweep new filings monthly.